| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 120.00 |
Costa Rica COVID-19 Vaccines Project
Abstract*
The US$120 million proposed Project would provide financing to the Government of Costa Rica to help finance its health sector response to the challenges imposed by the COVID-19. Specifically, the Project aims to support the acceleration of the COVID-19 vaccine rollout in a way that will ensure an effective COVID-19 response and generate long-lasting benefits. The proposed Project would provide financing to the Government of Costa Rica’s purchase and... Show More
Development Objective
The objective of the Project is to increase COVID-19 vaccination coverage among the population of the Republic of Costa Rica.
Key Details
Project Details
P178320
Closed
Laura Di Giorgio
Republic of Costa Rica
Costa Rica
February 15, 2022
(as of board presentation)
June 10, 2022
N/A
US$ 120.00 million
National Commission for Risk Prevention and Emergency Response (CNE)
2022
US$ 120.00 million
N/A
Substantial
November 15, 2022
Yes
BANK APPROVED
April 25, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 120.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 120.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 120.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Nov 15, 2022 | IBRD-94010 | Loan Cancel | 120,000,000.00 |
| Jun 10, 2022 | IBRD-94010 | Loan Commitment | 120,000,000.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Procurement | Satisfactory | 2022-11-08 |
| Project Management | Satisfactory | 2022-11-08 |
| Progress towards achievement of PDO | Satisfactory | 2022-11-08 |
| Financial Management | Satisfactory | 2022-11-08 |
| Monitoring and Evaluation | Satisfactory | 2022-11-08 |
| Overall Implementation Progress (IP) | Satisfactory | 2022-11-08 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Population vaccinated, which is included in the priority population targets defined in national plan Value 68.90 68.90 88.00 Date February 15, 2022 November 1, 2022 March 31, 2025 Comment Female population vaccinated, which is included in the priority population targets defined in national plan Value 70.60 70.60 0.00 Date Comment Male population vaccinated, which is included in the priority population targets defined in national plan Value 67.20 67.20 0.00 Date Comment Population that received booster vaccination (3rd dose or more), which is included in the priority population targets defined in national plan Value 7.40 7.40 60.00 Date February 16, 2022 November 1, 2022 March 31, 2025 Comment Female population that received booster vaccination (3rd dose or more), which is included in the priority population targets defined in national plan Value 7.40 7.40 0.00 Date Comment Male population that received booster vaccination (3rd dose or more), which is included in the priority population targets defined in national plan Value 7.40 7.40 0.00 Date Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
COVID-19 vaccines that meet the VAC procured Value 0.00 0.00 3500000.00 Date February 16, 2022 November 1, 2022 March 31, 2025 Comment Vaccine user satisfaction survey conducted and findings used to adjust the NSVP Value No No Yes Date February 16, 2022 November 1, 2022 March 31, 2025 Comment Female Indigenous Peoples vaccinated, which are included in the priority population targets defined in national plan (Percentage) Value 48.00 48.00 85.00 Date December 31, 2021 November 1, 2022 March 31, 2025 Comment Population 5-11 years old vaccinated, which is included in the priority population targets defined in national plan Value 0.00 0.00 12.00 Date December 30, 2021 November 1, 2022 March 31, 2025 Comment